RecruitingNot ApplicableNCT07416513

Digital Solutions for bEtter cAre

ALTHEA: tAckLing menTal Health Cancer Patients and Their Families: Digital Solutions for bEtter cAre


Sponsor

European Institute of Oncology

Enrollment

200 participants

Start Date

May 14, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The target population includes cancer patients, caregivers, family members, healthcare providers and mental health specialists, who will be the primary end-users of the Althea platform. For patients, survivors, caregivers, and family members, the sample variables include age, gender, type and stage of disease, and time since the first diagnosis. The healthcare professionals that will be involved in this study are those who attend to oncological patients, with sample variables such as age, gender, professional role, and prior experience and training in oncology or psycho-oncology.


Eligibility

Min Age: 12 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Patients, survivors, caregivers, family members and healthcare professionals for people with cancer diagnosis. The study is currently recruiting participants at 5 locations. People eligible for this study include aged 12 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPatients, survivors, caregivers, family members and healthcare professionals

Focus group discussions (FGD) and completion of survey


Locations(5)

Centre François Baclesse

Caen, France

Saarland University

Homburg, Germany

European Institute of Oncology

Milan, Italy, Italy

National Cancer Institute

Vilnius, Lithuania

Catalan Institute of Oncology

Barcelona, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07416513


Related Trials